Bioethics

Cache Raises Seed Financing to Advance its Biomolecule Storage Technologies

Retrieved on: 
星期二, 五月 7, 2024
Technology, Research, Genetics, Health Technology, Biotechnology, Health, Data Management, Other Science, Science, Pillar, Harvard University, University, Cancer, Cache, International Society, American College, Cell, Laboratory, AUC, Harvard Business School, University Health Network, Biological engineering, Genetic, Software, Biophysical environment, Area studies, Biochemistry, RNA, Doctor of Philosophy, University Medical Center, Pathology, San Francisco Bay Area, Intelligence, ACMG, Stanford University, George Church, Bioethics, Chemistry, Faculty, MIT, MBA, SBIR, Yale School of Management, Temperature, Ageing, National Science Foundation, Dicarboxylic acid, Biology, Medical genetics, Nucleation, Computer data storage

Cache DNA, Inc. , a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round.

Key Points: 
  • Cache DNA, Inc. , a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round.
  • The funds will help power R&D and support commercial development efforts and key partnerships to bring their solutions to market.
  • “Over the past three decades, sequencing technologies have evolved drastically.
  • It feels like every month, a new sequencing method is developed,” says Michael Becich, Cache CEO.

Pyx Health Expands Female-Forward Senior Leadership Team to Fuel Major Growth Strategy

Retrieved on: 
星期二, 四月 16, 2024
Lindenwood University, Education, School, Administration, University, Bioethics, Woman, Annie, Princeton University, Business administration, Life, Maryville University, Female, Risk management, Public policy, Privacy, Workforce, MBA, Government, Growth, Pyx, University of Arizona, Information system

TUCSON, Ariz., April 16, 2024 /PRNewswire/ -- Pyx Health, the leading social health platform solving loneliness, today announced that its Board of Directors has appointed Christina Rice, MBA, to president, and chief strategy officer, effective immediately. Co-founder Cindy Jordan will continue to serve as chief executive officer responsible for driving the company's direction, supervising other executives, and overseeing growth plans.

Key Points: 
  • Since 2018, she has served alongside Cindy Jordan as Pyx Health's chief operating officer, responsible for day-to-day operations while spearheading new strategies and growth opportunities.
  • As president, she oversees more than 200 employees nationwide and drives Pyx Health's service to 70+ healthcare clients and over 100,000 members.
  • "Pyx Health plays a critical role in the lives of those struggling with chronic loneliness across the country," said Rice.
  • Pyx Health's leadership team is comprised of 83% women and outpaces the national benchmarks for technology companies by employing an 81% female workforce.

Supreme Court Hears Oral Argument in Pivotal NCLA Case Against Gov’t Social Media Censorship

Retrieved on: 
星期一, 三月 18, 2024
CISA, Speech, Archive, Freedom, Ethics, COVID-19, Infection, Federation, White, Social media, Public policy, Constitution, First, Bioethics, Immunity, Kulldorff, CDC, Supreme court, DRS, Fifth, COVID-19 vaccine, Constitutional right, Safety, FBI, Injury, Paper, Government, Court, NCLA, Human

The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.

Key Points: 
  • The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.
  • We went to social media to voice our opinions and were silenced by government employees who bullied social media snowflakes into silencing our voices.
  • In the Murthy v. Missouri case, the Supreme Court has the opportunity to restore the First Amendment in this country.
  • That is what the government did here, and if that is allowed then the First Amendment is a dead letter.”

Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open - ResearchAndMarkets.com

Retrieved on: 
星期二, 三月 26, 2024
Health, Health Technology, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Diagnosis, ChromeOS, External, Learning, Partnership, Global health, Bioethics, Pleasure, Pharma

The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.
  • This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
  • It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.

CUTTING-EDGE RESEARCH SHAPING CHILDREN'S HEALTH SHOWCASED AT THE PEDIATRIC ACADEMIC SOCIETIES 2024 MEETING

Retrieved on: 
星期四, 四月 4, 2024
MB, Research, Seattle Children's, Health, Obesity, Bellevue Hospital, Aga Khan University, Perinatal stroke, Child, Health equity, Intelligence, Physician, Knowledge, Mental health, NYU, Doctor of Philosophy, Poverty, Adolescence, Metro Toronto Convention Centre, CME, Infection, Pediatrics, FAAP, PAS, Bioethics, Nursing

TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.

Key Points: 
  • TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.
  • Research on Neonatology, artificial intelligence, adolescent obesity, mental health, infectious diseases, and other health issues will be featured at the Pediatric Academic Societies (PAS) 2024 Meeting
    This unique meeting represents over 70 pediatric specialties and includes more than 350+ sessions, 687 oral abstracts, and 3,300+ posters on general and specialty pediatric health topics, as well as nine Friday pre-conference programs featuring topics on pediatric bioethics, perinatal stroke, kidney health, and more.
  • Attendees can access sessions, posters, and more through the online program guide and the PAS Meeting mobile app.
  • "This is the premier forum for pediatric researchers and providers to share the latest research on global and public health issues," Judith Shaw, PAS program chair.

Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open

Retrieved on: 
星期二, 三月 26, 2024
Diagnosis, ChromeOS, External, Learning, Partnership, Global health, Bioethics, Pleasure, Biotechnology, Pharma, Pharmaceutical industry

DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.
  • This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
  • It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.

Susan G. Komen® Strengthens Leadership with Strategic Appointments to Board of Directors

Retrieved on: 
星期三, 三月 20, 2024
J. P. Morgan, Entrepreneurship, AIG, General partnership, Bachelor of Arts, Artificial intelligence, Duke University, Chairperson, Research, Harvard Business School, Executive Committee, University, Portfolio management, Bioethics, High-yield debt, Chemistry, Breast cancer, Partner, GoldenTree Asset Management, Sony Pictures, Aignan, AVP, Management

DALLAS, March 20, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, today announced four new global leaders to serve on its Board of Directors. These appointments mark a significant milestone in the organization's continued commitment to advancing breast cancer research, awareness and support. The newly appointed board members bring a wealth of experience and expertise to the organization, further fortifying Komen's mission to end breast cancer forever.

Key Points: 
  • These appointments mark a significant milestone in the organization's continued commitment to advancing breast cancer research, awareness and support.
  • "Komen's new board members join a legacy of passionate individuals who have dedicated themselves to making a difference," said Paula Schneider, president & CEO, Susan G. Komen.
  • Kathy Sutherland, Partner & Chief Executive Officer at GoldenTree Asset Management, brings a wealth of financial acumen and strategic leadership to the board.
  • Additional information on the Board of Directors and individual Board members can be found here: https://www.komen.org/about-komen/our-people/ .

TerraSafe Materials and Penn State Announce Licensing Agreement to Commercialize Breakthrough Material Technologies

Retrieved on: 
星期二, 二月 27, 2024
Pennsylvania State University, Adhesive, Commercialization, Research, State College, Pennsylvania, Innovation Park, Research and development, Biological engineering, Polysaccharide, Food packaging, Wood, Building material, Starch, Hope, Food, Cellulose, BIV, State, GFRP, Microplastics, Ecosystem, Bioethics, Associate, Intellectual property, Agriculture, AG, PSU

TerraSafe is launching its first rural Research & Development facility at the Penn State Innovation Park, where the Company plans to run analytic testing for new material technologies in development.

Key Points: 
  • TerraSafe is launching its first rural Research & Development facility at the Penn State Innovation Park, where the Company plans to run analytic testing for new material technologies in development.
  • TerraSafe is leveraging intellectual property created by researchers at the Pennsylvania State University (“PSU”) in the biomaterials space.
  • “The support that this ecosystem can bring to startups like TerraSafe is why we located our first R&D center in State College.
  • The collaboration between TerraSafe and Penn State marks a major milestone of its core mission to build and grow companies throughout the rural United States.

"This Penis Business: A Memoir" Chronicles the Life Events That Compelled Georganne Chapin to Make Ending Circumcision Her Life's Work

Retrieved on: 
星期二, 二月 20, 2024
Bioethics, Woman, Shame, Pain, Cruelty, Female, Masturbation, Parent, Life, AAP, Face, Pseudoscience, Intact America, Fear, Anatomy, Child, Male, Movement, Foreskin, Trauma, American Academy, Barnes & Noble, Pediatrics (journal), Book

TARRYTOWN, N.Y., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Chapin, Co-Founder and Executive Director of Intact America, Exposes the Big Business of Medical Circumcision and the Cruel Absurdity of Circumcising Baby Boys for No Medical Reason

Key Points: 
  • I chose to write a memoir about why I believe cutting the genitals of children who cannot consent is a massive human rights abuse," says Chapin.
  • But it wasn't until she went to law school mid-career and studied bioethics that Chapin turned to intactivism, the human rights movement dedicated to ending routine circumcision of baby boys in the United States.
  • "I wanted to write a book exposing the multi-billion-dollar medical circumcision business in the United States.
  • "This Penis Business" is available from Amazon , Barnes & Noble , and Bookshop , as well as local bookstores near you.

Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials

Retrieved on: 
星期三, 一月 31, 2024
Education, Health, Technology, Health Technology, Software, Clinical Trials, University, Multimedia, Male, Booth, Research, AI, Population health, Clinical trial, News, Drug, Patient, Bioethics, IPad, Duke, Hypertension, Comprehension, EIC, Associate, Doctor of Philosophy, American Opportunity Tax Credit, SCOPE, ROI, Pharmaceutical industry

Medable Inc. , the leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials.

Key Points: 
  • Medable Inc. , the leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials.
  • “[The enhanced eIC] is more appealing to me as a human being, not just a study subject,” said a 63-year-old male participant.
  • In related news, Medable launched its intelligent automation technology to reduce clinical trial technology deployment by 50%, taking eCOA off the critical path to study startup.
  • *NOTE: The Duke/Medable eIC study results should be taken as directional and further confirmed in a larger study.